Capstone Investment Advisors »

Denali Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $641k 39k 16.51
2024-03-31 $405k 20k 20.52
2023-12-31 $491k 23k 21.46
2023-09-30 $775k 38k 20.63